Back to top
more

Lantheus (LNTH)

(Delayed Data from NSDQ)

$97.33 USD

97.33
648,582

+0.07 (0.07%)

Updated Aug 9, 2024 04:00 PM ET

After-Market: $97.39 +0.06 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights QuidelOrtho, Lantheus and TG Therapeutics

QuidelOrtho, Lantheus and TG Therapeutics are part of Zacks Industry Outlook article.

Centene (CNC) to Sell Magellan Arm, To Use Proceeds for Buybacks

Centene (CNC) strikes a deal with Evolent to divest Magellan Specialty Health, a Magellan Health arm, to deepen focus on solidifying its core Managed Care business.

Indrajit Bandyopadhyay headshot

3 Medical Products Stocks Navigating Industry Challenges

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. QDEL, LNTH and TGTX are well-poised to gain from the favorable factors.

Lantheus Holdings (LNTH) Tops Q3 Earnings and Revenue Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 19.28% and 4.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

What Awaits Lantheus Holdings (LNTH) This Earnings Season?

Lantheus Holdings' (LNTH) third-quarter results are likely to reflect solid top line results on the back of robust product adoption.

AMN Healthcare (AMN) to Post Q3 Earnings: What's in the Cards?

AMN Healthcare's (AMN) third-quarter results are likely to reflect solid demand across all its segments.

How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Lantheus Holdings (LNTH) Gains But Lags Market: What You Should Know

Lantheus Holdings (LNTH) closed the most recent trading day at $75.45, moving +1.95% from the previous trading session.

Lantheus Holdings (LNTH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Lantheus Holdings (LNTH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why "Trend" Investors Would Love Betting on Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Molina Healthcare (MOH) to Post Q3 Earnings: What to Expect

Molina Healthcare's (MOH) Q3 results are expected to reflect better premiums and membership growth in its Medicaid and Medicare businesses, partly offset by steep general and administrative costs.

Lantheus Holdings (LNTH) Gains But Lags Market: What You Should Know

In the latest trading session, Lantheus Holdings (LNTH) closed at $72.33, marking a +0.86% move from the previous day.

Lantheus Holdings (LNTH) Upgraded to Buy: What Does It Mean for the Stock?

Lantheus Holdings (LNTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Are Medical Stocks Lagging Lantheus (LNTH) This Year?

Here is how Lantheus Holdings (LNTH) and Pharming Group N.V. Sponsored ADR (PHAR) have performed compared to their sector so far this year.

Why Lantheus Holdings (LNTH) is Poised to Beat Earnings Estimates Again

Lantheus Holdings (LNTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Lantheus Holdings (LNTH) Gains As Market Dips: What You Should Know

Lantheus Holdings (LNTH) closed the most recent trading day at $67.04, moving +1.22% from the previous trading session.

Lantheus Holdings (LNTH) Gains As Market Dips: What You Should Know

Lantheus Holdings (LNTH) closed the most recent trading day at $77.67, moving +1.17% from the previous trading session.

Why Should You Retain Cigna (CI) in Your Portfolio Now?

Cigna (CI) is aided by powerful segmental performances, solid demand for its Medicare plans, divestitures and solid cash-generating abilities.

Factors That Make Centene (CNC) an Attractive Bet for Investors

Centene (CNC) rides on continued top-line growth and numerous contract wins. Divestitures and an adequate cash-generating ability equip CNC well to invest in growth-related initiatives.

Molina Healthcare (MOH) Wins Medicaid Deal From Nebraska DHHS

Molina Healthcare (MOH) clinches a contract from the Nebraska DHHS, through which the health insurer can efficiently serve the state's Medicaid members and boost its statewide presence.

Lantheus Holdings (LNTH) Gains As Market Dips: What You Should Know

Lantheus Holdings (LNTH) closed the most recent trading day at $67.39, moving +1.19% from the previous trading session.